Email Newsletters

Framingham

HeartWare Buys NJ Firm For $30M

HeartWare International of Framingham has bought a New Jersey-based medical device manufacturer in a deal that could wind up being worth $350 million.

Despite Ruling, CEO Wants To Redevelop Marist Site

Despite a denial for a special permit to renovate and expand the former Marist Retreat Center in Framingham, Walden Behavioral Care CEO Stuart Koman said he remains “firmly committed” to pursuing approval — this time through an appeal in land court. Walden, a Waltham-based treatment center for people with eating and mood disorders, filed for a special permit to renovate and expand the site on Pleasant Street (Route 30), to accommodate its new headquarters and an 80-bed treatment facility.

Rand Announces Data Division Rebranding

Framingham-based Rand Worldwide, a provider of data governance products, announced a rebranding of its former Rand Secure Archive division after expanding its range of services.

Biotech Blooms In ‘Burbs

Jon Delli Priscoli looked to Cambridge for inspiration as he sought to make his mark in MetroWest.The...
ADVERTISEMENT

Ameresco Close to Landing Army Solar Deal

Framingham-based Ameresco received a notice of intent Friday for a contract to build an 18.6 megawatt solar plant for the U.S. Army in Maryland.

FSU Names Finalists For Presidency

The Board of Trustees of Framingham State University has announced three final candidates for the presidency following the departure of FSU's last president, Timothy J. Flanagan, in May.

Staples Reports Revenue Drop; Profits Up

Third-quarter revenue for Staples fell nearly 4 percent as the Framingham-based office supply retailer cited weak demand for “core” office supplies, but growth in its online sales channels.

TJX Profits Up 35%

Fiscal third-quarter earnings rose 35 percent at The TJX Cos. of Framingham based off improvements in same-store sales.
ADVERTISEMENT

FDA Slams Genzyme’s MS Drug

U.S. regulators said Friday that the risks from a multiple sclerosis (MS) drug developed by Cambridge-based Genzyme might outweigh its benefits and recommended against the drug's approval.

Packaging Firm Announces Holliston Plant Closure, Layoffs

Consolidation of an Avery Dennison segment acquired by Toronto-based specialty packaging company CCL Industries, Inc. will result in the closure of supply chain operations in Holliston and the majority of its employees will be laid off as of Feb. 1, according to Sean Washchuk, chief financial officer for CCL. The segment, a consumer office products business called Avery, is part of a consolidation of operations in the United States, Canada and Mexico, according to a statement released by the company Oct. 30. The company's other Massachusetts supply chain operations in Chicopee are also slated to close. The consolidation will impact 250 Mass. employees, with only a small group of employees relocating and keeping their jobs, according to Washchuk. He declined to disclose the number of employees located in Holliston. No one answered the phone Monday afternoon at the Holliston location at 89 Cross St.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA